LONDON BROKER RATINGS: Price targets raised for BP and Shell
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More
| Price | 2,151.00p on 03-03-2026 at 08:27:53 |
|---|---|
| Change | -29.00p -1.33% |
| Buy | 2,152.00p |
| Sell | 2,150.00p |
| Last Trade: | Sell 353.00 at 2,150.00p |
| Day's Volume: | 403,825 |
| Last Close: | 2,180.00p |
| Open: | 2,165.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,149.00p - 2,171.00p |
| 52wk Range: | 1,242.50p - 2,282.00p |
| Market Capitalisation: | £86.28b |
| VWAP: | 2,161.4746p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 353 | 2,150.00p | SI Trade |
08:27:53 - 03-Mar-26 |
| Buy* | 29 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Buy* | 91 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Buy* | 679 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Buy* | 679 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Buy* | 679 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Unknown* | 41 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Buy* | 679 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Buy* | 679 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
| Buy* | 169 | 2,151.00p | Automatic Execution |
08:27:50 - 03-Mar-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Mar 2026 3:00 pm | RNS | Total Voting Rights |
| 2nd Mar 2026 7:00 am | RNS | Transaction in Own Shares |
| 27th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 27th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 26th Feb 2026 7:05 am | RNS | Linerixibat accepted for priority review in China |
| 26th Feb 2026 7:00 am | RNS | Bepirovirsen accepted for Japan regulatory review |
| 26th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 25th Feb 2026 4:54 pm | RNS | Director/PDMR Shareholding |
| 25th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 25th Feb 2026 7:00 am | RNS | GSK enters agreement to acquire 35Pharma |